Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03963752
Other study ID # 18401902300
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 15, 2019
Est. completion date September 30, 2022

Study information

Verified date February 2024
Source Children's Hospital of Fudan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our study used a randomized controlled trial to validate the clinical efficacy of a combination of traditional Chinese and Western medicine in the treatment of children with rapid progressive central precocious puberty.


Description:

In the research, 164 subjects diagnosed with rapid progressive idiopathic precocious puberty are randomly divided into Group Ziyinxiehuo Granules and Megestrol Acetate Tablet(82 cases)and Group Gonadotrophin ( 82 cases). Patients in Group Ziyinxiehuo Granules and Megestrol Acetate Tablet are treated with ziyinxiehuo Granules and megestrol acetate tablet , whereas the Group Gonadotrophin received with gonadotrophin releasing hormone agonist, and all the subjects in two groups are continuously treated for 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 126
Est. completion date September 30, 2022
Est. primary completion date August 15, 2022
Accepts healthy volunteers No
Gender Female
Age group 5 Years to 8 Years
Eligibility Inclusion Criteria: - Girls are diagnosed as Idiopathic central precocious puberty by GnRH (gonadotrophin releasing hormone)Stimulation Test, and their age of onset =8 years; - Tanner stages of breast in female patients = Tanner III stage,diameter of mammillary nucleus = 3cm; - B-type ultrasonography: the volume of uterus=3ml, the volume of ovary=1.5ml, the diameter of follicle=4mm; - Bone age: compared the chronological age, the bone age is more than 1 year and the bone age <11.5 years old; - It progresses rapidly, ratio of bone age difference to chronological age difference> 1; - No GnRH analogs or sex hormones were administrated in the past; - All above are needed at the same time. Exclusion Criteria: - Precocious precocity caused by the central nervous system organic diseases; - Precocious precocity caused by congenital hypothyroidism, congenital adrenal hyperplasia, adrenal tumor and ovarian or testicular neoplasms as well as McCune-Albright syndrome, etc; - Precocious precocity with a family history of diseases such as tumor, leukemia, diabetes, systemic lupus erythematous; - Pseudo sexual precocity and partial precocious puberty.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ziyinxiehuo Granules Herbs
1 pack of Ziyinxiehuo granules Herbs is administered after dissolved, 2 times per day after a meal.
Megestrol Acetate Tablet
the dose is 6-8mg/d, three times per day after meals.
Leuprorelin Acetate 3.75mg Injection
Usage: 80µg/kg by subcutaneous injection, every 4 weeks

Locations

Country Name City State
China Children's Hospital of Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital of Fudan University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of the Mammary Nucleus Diameter reduced to less than 1cm The investigators will measure subjects' mammary nucleus diameter through the midline of the breast with a ruler after six months of continuous treatment, and percentage of the mammary nucleus diameter reduced to less than 1cm in each group will be calculated. After six months of continuous treatment
Secondary Ratio of bone age difference to chronological age difference The left hand orthotopic X-ray (including the carpal bone and the lower end of the ulna) will be filmed by the Department of Radiology before and after treatment, and the bone age will be measured according to the Greulich-Pyle map method. Ratio of bone age difference to chronological age difference will be calculated. After six months of continuous treatment